Parkinson's treatment could be more effective, student finds

January 4, 2018, Binghamton University

A Binghamton University senior and her colleagues recently uncovered evidence that the current treatment for Parkinson's disease may not be as effective as it could be.

Lakshmi Hareendran was part of a research team investigating drug treatment for Parkinson's, a neurodegenerative disorder caused by a loss of the chemical dopamine.

The dopamine circuit involved in motor movements consists of two receptors in the brain, the D1 and the D2 receptors. The current treatment for Parkinson's is the drug L-DOPA, which acts on both of these receptors to release and replenish dopamine in the brain.

Hareendran and her colleagues in the Freshman Research Immersion program (FRI) at Binghamton provided evidence that stimulating the D2 receptor produces cognitive deficits, illustrating that L-DOPA may not be the best treatment for Parkinson's.

The researchers treated rodents with L-DOPA and drugs that target either the D1 or the D2 receptors and then observed the effects on their ability to complete a behavioral task.

Stimulating the D2 receptor caused attention deficits on the behavioral tasks in both Parkinson's and control models. Stimulating the D1 receptor produced no such effects.

"Parkinson's disease is one of the most common neurodegenerative diseases in the world," Hareendran says. "Knowing that the current treatment isn't as effective as it could be is important."

Hareendran, 21, has wanted to be a doctor since she was growing up on Long Island, influenced by several doctors in her family. Even then, she was interested in neuroscience.

"I had an uncle who was a brain surgeon," Hareendran says. "As a kid, just thinking about him being able to understand something as complex as the human brain really inspired me to go down that path."

Hareendran wants to work with Doctors Without Borders someday. An experience with MEDLIFE, an organization that provides medical care to impoverished areas, helped to solidify her goal. Hareendran traveled with the group to Peru and Ecuador to help set up medical clinics.

"My parents are refugees from Sri Lanka," Hareendran says. "There was a genocide happening there for a while, so specifically with Doctors Without Borders I want to go and give back there."

Hareendran is also president of the Indian International Student Union and was a peer mentor for FRI after she finished the program.

Corinne Kiessling, research educator for the FRI neuroscience stream, emphasized Hareendran's dedication.

"She was one of those students that puts extra hours in, came in early, stayed late," Kiessling says. "As a peer mentor, she was very open and receptive, and she challenged students to find answers. She's a natural leader."

Explore further: New drug may treat and limit progression of Parkinson's disease

More information: … reads-with-Cover.pdf

Related Stories

New drug may treat and limit progression of Parkinson's disease

July 31, 2017
Researchers at Binghamton University have developed a new drug that may limit the progression of Parkinson's disease while providing better symptom relief to potentially hundreds of thousands of people with the disease.

Parkinson's disease drug shows anticancer effects

September 28, 2017
Research shows the Parkinson's disease drug carbidopa displays significant anticancer effects in both human cell lines and mice when given at normal patient dosage levels.

New technique can provide better cell transplants against Parkinson's disease

May 5, 2016
Researchers at Lund University in Sweden have used a completely new preclinical technique and analysis of tissue from patients to show exactly what happens when certain patients with Parkinson's disease are restored as a ...

New avenue to treat diabetes-related vision problems

January 22, 2014
Dopamine-restoring drugs already used to treat Parkinson's disease may also be beneficial for the treatment of diabetic retinopathy, a leading cause of blindness in adults, researchers have discovered.

Intracellular dopamine receptor function may offer hope to schizophrenia patients

December 9, 2016
Dopamine is a chemical in the brain that plays an important role in controlling movement, emotion and cognition. Dopamine dysfunction is believed to be one of the causes of disorders like Schizophrenia, Tourette's syndrome, ...

Recommended for you

Parkinson's gene initiates disease outside of the brain

March 21, 2018
Until very recently, Parkinson's had been thought a disease that starts in the brain, destroying motion centers and resulting in the tremors and loss of movement. New research published this week in the journal Brain, shows ...

Faulty cellular membrane 'mix' linked to Parkinson's disease

March 15, 2018
Working with lab-grown human brain cells, Johns Hopkins researchers report they have uncovered a much sought-after connection between one of the most common genetic mutations in Parkinson's disease and the formation of fatty ...

Researchers uncover culprit in Parkinson's brain cell die-off

March 5, 2018
An estimated 10 million people worldwide are living with Parkinson's disease—an incurable neurodegenerative disorder that leads to an increasing loss of motor control.

Study uncovers cause of cell death in Parkinson's disease

February 26, 2018
A University of Guelph researcher has discovered one of the factors behind nerve cell death in Parkinson's disease, unlocking the potential for treatment to slow the progression of this fatal neurodegenerative disorder.

Protein levels in spinal fluid correlate to posture and gait difficulty in Parkinson's

February 21, 2018
Levels of a protein found in the brain called alpha-synuclein (α-syn) are significantly lower than normal in cerebrospinal fluid collected in Parkinson's disease patients suffering from postural instability and gait difficulty, ...

Calcium may play a role in the development of Parkinson's disease

February 19, 2018
Researchers have found that excess levels of calcium in brain cells may lead to the formation of toxic clusters that are the hallmark of Parkinson's disease.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.